NDC 16714-156

POSACONAZOLE

Posaconazole

POSACONAZOLE is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Northstar Rxllc. The primary component is Posaconazole.

Product ID16714-156_76596a89-5f38-4183-b374-89d138df270f
NDC16714-156
Product TypeHuman Prescription Drug
Proprietary NamePOSACONAZOLE
Generic NamePosaconazole
Dosage FormTablet, Delayed Release
Route of AdministrationORAL
Marketing Start Date2021-05-18
Marketing CategoryANDA /
Application NumberANDA212411
Labeler NameNorthStar RxLLC
Substance NamePOSACONAZOLE
Active Ingredient Strength100 mg/1
Pharm ClassesAzole Antifungal [EPC],Azoles [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 16714-156-01

60 TABLET, DELAYED RELEASE in 1 BOTTLE (16714-156-01)
Marketing Start Date2021-05-18
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "POSACONAZOLE" or generic name "Posaconazole"

NDCBrand NameGeneric Name
0254-2045POSACONAZOLEposaconazole
0406-7711POSACONAZOLEposaconazole
0527-2133POSACONAZOLEPosaconazole
60687-523PosaconazolePosaconazole
70748-258POSACONAZOLEPOSACONAZOLE
0085-1328NOXAFILposaconazole
0085-2224NOXAFILposaconazole
0085-4324NOXAFILposaconazole
0085-4331NOXAFILposaconazole

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.